Date: 2015-07-31
Type of information: Resignation
Compound:
Company: TiGenix (Belgium)
Therapeutic area:
Type agreement: resignation
Action mechanism:
Disease:
Details: * On July 31, 2015, TiGenix announced that Dirk Büscher and José Terencio resigned from their position as board member, effective as of July 31, 2015. Dirk Büscher and José Terencio are the CEO and COO respectively of Gri-Cel SA, a fully owned subsidiary of Grifols, a world leader in plasma-derived therapeutics.
Financial terms:
Latest news:
